| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Institut National de la Santé et de la Recherche Médicale U45, Hôpital E. Herriot, 69437 Lyon Cedex 3, France [J. C. S., E. N-G., J. C. C., J. A., J. A. C.]; Department of Experimental Pathology, Swiss Institute for Cancer Research (Isrec), 1066 Epalinges, Switzerland [B. S.]; and Tulane University, New Orleans, Louisiana 70112-2699 [D. H. C.]
The neuropeptide bombesin and its mammalian homologue, gastrin-releasing peptide (GRP), enhance proliferation in some but not all human tumor cell lines. The pathophysiological relevance of the bombesin/GRP receptor (GRP-R), which is expressed in 30% of human colon tumor cell lines and in 2440% of native tumors, has not been clearly assessed at this time. We studied the effects of bombesin in the recently characterized human colon carcinoma Isreco1 cell line. Competitive reverse transcription-PCR showed a high GRP-R mRNA level in Isreco1 cells, and binding studies confirmed the expression of bombesin/GRP-subtype receptors (Kd = 0.42 nM; Bmax = 18,000 sites/cell). Exposure to bombesin resulted in an increase of intracellular calcium concentrations. Bombesin (1 nM) induced cell spreading at 24 h (21.7 ± 1.6% versus 6.4 ± 0.8% in control cells; P < 0.01) and markedly increased the formation of lamellipodia. In addition, adhesion of Isreco1 cells to collagen I-coated culture dishes was stimulated in the presence of 1 nM bombesin (69 ± 6% versus 42 ± 1% in control cells; P < 0.01). Finally, bombesin significantly increased [3H]thymidine uptake by Isreco1 cells in a dose-dependent manner, with a first significant response at 0.1 nM and a maximal effect at 100 nM bombesin (192.2 ± 9.7% of control). These results clearly indicate that bombesin exerts morphological, adhesive, and proliferative effects on Isreco1 cells, suggesting that expression of the bombesin/GRP-R may contribute to the malignant properties of colon carcinoma cells.
This article has been cited by other articles:
![]() |
S. Glover, R. Nathaniel, L. Shakir, C. Perrault, R. K. Anderson, R. Tran-Son-Tay, and R. V. Benya Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1274 - G1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Laine, M.-C. Trescol-Biemont, S. Longhi, G. Libeau, J. C. Marie, P.-O. Vidalain, O. Azocar, A. Diallo, B. Canard, C. Rabourdin-Combe, et al. Measles Virus (MV) Nucleoprotein Binds to a Novel Cell Surface Receptor Distinct from Fc{gamma}RII via Its C-Terminal Domain: Role in MV-Induced Immunosuppression J. Virol., November 1, 2003; 77(21): 11332 - 11346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Saurin, M. Fallavier, B. Sordat, J.-C. Gevrey, J.-A. Chayvialle, and J. Abello Bombesin Stimulates Invasion and Migration of Isreco1 Colon Carcinoma Cells in a Rho-dependent Manner Cancer Res., August 15, 2002; 62(16): 4829 - 4835. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |